Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Albemarle will sell Thann site
August 14, 2006
| A version of this story appeared in
Volume 84, Issue 33
Albemarle has reached an agreement to sell its organobromides plant in Thann, France, to International Chemical Investors Group for an undisclosed sum. Earlier this year, Albemarle said it planned to close the facility, which employs 300 people. ICIG has been on the acquisition trail. Last June, the firm acquired fine chemicals, organics, and performance chemical businesses from Rütgers and formed WeylChem. In October, it bought the Enka viscose fiber subsidiary of Acordis.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter